BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1397 related articles for article (PubMed ID: 19696695)

  • 1. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
    Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
    Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.
    Lonjou C; Borot N; Sekula P; Ledger N; Thomas L; Halevy S; Naldi L; Bouwes-Bavinck JN; Sidoroff A; de Toma C; Schumacher M; Roujeau JC; Hovnanian A; Mockenhaupt M;
    Pharmacogenet Genomics; 2008 Feb; 18(2):99-107. PubMed ID: 18192896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.
    Kulkantrakorn K; Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Prabmechai N; Vannaprasaht S; Chumworathayi P; Chen P; Sritipsukho P
    Pain Pract; 2012 Mar; 12(3):202-8. PubMed ID: 21676164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Cristallo AF; Schroeder J; Citterio A; Santori G; Ferrioli GM; Rossi U; Bertani G; Cassano S; Gottardi P; Ceschini N; Barocci F; Ribizzi G; Cutrupi V; Cairoli R; Rapisarda V; Pastorello EA; Barocci S
    Int J Immunogenet; 2011 Aug; 38(4):303-9. PubMed ID: 21545408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.
    Halevy S; Ghislain PD; Mockenhaupt M; Fagot JP; Bouwes Bavinck JN; Sidoroff A; Naldi L; Dunant A; Viboud C; Roujeau JC;
    J Am Acad Dermatol; 2008 Jan; 58(1):25-32. PubMed ID: 17919772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population.
    Gonçalo M; Coutinho I; Teixeira V; Gameiro AR; Brites MM; Nunes R; Martinho A
    Br J Dermatol; 2013 Sep; 169(3):660-5. PubMed ID: 23600531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China.
    Wu XT; Hu FY; An DM; Yan B; Jiang X; Kwan P; Stefan H; Zhou D
    Epilepsy Behav; 2010 Nov; 19(3):405-8. PubMed ID: 20833111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: what causes the diversity?
    Dainichi T; Uchi H; Moroi Y; Furue M
    Dermatology; 2007; 215(1):86-8. PubMed ID: 17587850
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic utility of HLA-B*5801 screening in severe allopurinol hypersensitivity syndrome: an updated systematic review and meta-analysis.
    Yu KH; Yu CY; Fang YF
    Int J Rheum Dis; 2017 Sep; 20(9):1057-1071. PubMed ID: 28857441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.
    Chung WH; Hung SI
    Allergol Int; 2010 Dec; 59(4):325-32. PubMed ID: 20962567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic predisposition of life-threatening antiepileptic-induced skin reactions.
    Chung WH; Hung SI; Chen YT
    Expert Opin Drug Saf; 2010 Jan; 9(1):15-21. PubMed ID: 20001755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.
    Hung SI; Chung WH; Liou LB; Chu CC; Lin M; Huang HP; Lin YL; Lan JL; Yang LC; Hong HS; Chen MJ; Lai PC; Wu MS; Chu CY; Wang KH; Chen CH; Fann CS; Wu JY; Chen YT
    Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4134-9. PubMed ID: 15743917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stevens-Johnson syndrome and toxic epidermal necrolysis--updates and innovations].
    Halevy S
    Harefuah; 2010 Mar; 149(3):186-90, 193. PubMed ID: 20684173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Kim SH; Kim M; Lee KW; Kim SH; Kang HR; Park HW; Jee YK
    Pharmacogenomics; 2010 Jun; 11(6):879-84. PubMed ID: 20504258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs.
    Park HJ; Kim YJ; Kim DH; Kim J; Park KH; Park JW; Lee JH
    Yonsei Med J; 2016 Jan; 57(1):118-26. PubMed ID: 26632391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of toxic epidermal necrolysis.
    Lee MT; Hung SI; Wei CY; Chen YT
    Expert Opin Pharmacother; 2010 Sep; 11(13):2153-62. PubMed ID: 20536296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand.
    Rattanavipapong W; Koopitakkajorn T; Praditsitthikorn N; Mahasirimongkol S; Teerawattananon Y
    Epilepsia; 2013 Sep; 54(9):1628-38. PubMed ID: 23895569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population.
    Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Chen P; Lin SY; Chen WH; Konyoung P; Khunarkornsiri U; Auvichayapat N; Pavakul K; Kulkantrakorn K; Choonhakarn C; Phonhiamhan S; Piyatrakul N; Aungaree T; Pongpakdee S; Yodnopaglaw P
    Epilepsia; 2010 May; 51(5):926-30. PubMed ID: 20345939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency.
    Jung JW; Song WJ; Kim YS; Joo KW; Lee KW; Kim SH; Park HW; Chang YS; Cho SH; Min KU; Kang HR
    Nephrol Dial Transplant; 2011 Nov; 26(11):3567-72. PubMed ID: 21393610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis.
    Chung WH; Hung SI
    J Dermatol Sci; 2012 Jun; 66(3):190-6. PubMed ID: 22541332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.